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We	 identified	 281	Vibrio cholerae	 non-O1,	 non-O139	
strains	from	patients	with	diarrhea	in	Kolkata,	India.	Cholera-
like	diarrhea	was	the	major	symptom	(66.0%);	some	patients	
(20.3%)	 had	 severe	 dehydration.	 These	 strains	 lacked	 
the	 ctxA	 gene	 but	many	 had	hlyA,	 rtxA,	 and	 rtxC genes.	
Pulsed-field	 gel	 electrophoresis	 showed	 no	 genetic	 link	
among	strains.
Vibrio cholerae O1 has been responsible for several cholera outbreaks in developing countries. During 
1992, a novel serogroup, O139, caused cholera outbreaks 
in India and other countries in Asia (1). These events 
have shown that serogroups other than O1 have major 
epidemiologic roles in cholera. V. cholerae O1 and O139 
serogroups produce cholera toxin (CT), a critical virulence 
factor and express toxin coregulated pilus (TCP), which 
are responsible for secretory diarrhea and intestinal 
colonization, respectively. Serogroups other than O1 and 
O139 are designated as V. cholerae non-O1, non-O139, or 
nonagglutinating vibrios (NAGs); such serogroups have 
>200 somatic (O) antigens (2) and mostly lack CT- and 
TCP-coding genes.
Toxigenic and nontoxigenic NAGs have caused several 
diarrhea outbreaks in India and other countries, including 
Haiti (3–6). In non–CT-producing NAGs, other virulence 
factors such as heat-stable enterotoxin (Stn), hemolysin 
(HlyA), repeat in toxin (RTX), and type 3 secretion systems 
(TTSS) have major roles in causing infections (7). In this 
study, we analyzed clinical characteristics of hospitalized 
patients with diarrhea infected with NAGs and screened 
strains for antimicrobial drug susceptibility, virulence 
genes, and genetic relatedness.
The Study
During 2002–2010, a total of 12,719 fecal specimens 
were collected, which represented every fifth hospitalized 
diarrhea patient at the Infectious Diseases Hospital in 
Kolkata and all children at the outpatient unit at B.C. 
Roy Memorial Hospital for Children in Kolkata. Fecal 
specimens were screened for V. cholerae and other enteric 
pathogens as described (8). NAGs were serotyped by 
using 206 polyclonal O antisera according to the protocol 
developed at the National Institute of Infectious Diseases 
(Tokyo, Japan) (2).
Antimicrobial drug susceptibility assays were 
performed by using the disk diffusion method and 
commercially available disks (Becton Dickinson, Sparks 
Glencoe, MD, USA), according to standards of the 
Clinical and Laboratory Standards Institute (9). Because 
these standards do not include interpretive criteria for 
V. cholerae, breakpoints for Enterobacteriaceae were 
adopted. Escherichia coli ATCC 25922 was used as a 
quality-control strain.
Simplex and multiplex PCRs were performed by 
using published methods specific for ctxA, tcpA, rtxA, 
rtxC, stn, and hlyA genes (classical/El Tor) and the 
TTSS-coding genes (7). Pulsed-field gel electrophoresis 
was performed according to the PulseNet standardized 
protocol for V. cholerae (www.pulsenetinternational.
org /Si teCol lec t ionDocuments /pfge /5 .71_2009_
PNetStandProtVcholerae.pdf. Gel Compare II software 
(Applied Maths NV, Sint-Martens-Latem, Belgium) was 
used for comparison of electrophoresis patterns. This 
software uses a Dice similarity index and contains an 
unweighted pair group with arithmetic mean method.
Of the 12,719 diarrhea feces specimens screened, 
2,206 (17.3%) contained V. cholerae, which included V. 
cholerae O1 in 1,841 (83.4%), and O139 in 84 (3.8%). In 
the remaining 281 (12.7%) specimens, V. cholerae strains 
did not agglutinate with serogroups O1 or O139. This result 
was confirmed by species-specific ompW PCR, which 
included strains collected during 2003 (7). Among 281 
strains, 175 (62.3%) NAGs were the only enteric pathogen 
found, and 106 (37.7%) of those NAGs were found with 
other enteric pathogens. The isolation frequency of NAGs 
ranged from 1.2% to 3.2% (Table 1).
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Although V. cholerae O1 is highly prevalent in Kolkata, 
more NAGs were detected than in our previous study (10). 
A total of 224 (79.7%) strains were categorized into 80 
serogroups; the remaining 57 (20.3%) were untypeable. 
Among typeable serogroups, 14 (6.2%) strains belonged 
to the O37 serogroup, and 11 (4.9%) each belonged to 
serogroups O6 and O34. Serogroups O97 (4.5%), O11 
(3.6%), and O59 (3.1%) were also identified in this study. 
Although serogroups O11, O35, and O37 showed a lower 
prevalence, their prevalence was higher among patients 
with diarrhea in Kolkata (7,10). The prevalence rate of 
NAGs (≈2%) in Kolkata is similar to that in the Haizhu 
District of Guangzhou, China (11). However, the number 
of serogroups identified in China (26 serogroups) was less 
than in our study (80 serogroups).
Among age groups of patients, NAGs were detected 
mostly in patients >5 years of age (>72%) than in those <5 
years of age (≈28%) (Table 2). NAGs produce a spectrum 
of gastrointestinal symptoms ranging from asymptomatic 
infection to severe cholera-like illness or bloody diarrhea. 
In this study, most (70%) patients had watery diarrhea, 
which was similar to that for patients with cholera and 
those exclusively infected by NAGs (Table 2). Other 
clinical symptoms, such as dehydration status (22.3%) 
and fever (41.1%), were also high in patients with a 
single infection. In patients with mixed infections, bloody 
diarrhea (23.6%) and abdominal pain (41.5%) were the 2 
major symptoms (Table 2), perhaps because >1 pathogen 
was involved.
Most NAGs were resistant to nalidixic acid (57.6%), 
ampicillin (55.5%), furazolidone (36.6%), and streptomycin 
(32.4%) and highly susceptible to gentamicin (96%), 
tetracycline (80%), and chloramphenicol (80.4%). During 
1992–1997, antimicrobial drug resistance was high among 
V. cholerae isolated in Kolkata (12). In this study, patterns 
of antimicrobial drug resistance in NAGs were different 
than those in previous reports (10,12). This finding might 
be caused by discontinuation of ineffective antimicrobial 
drugs, such as co-trimoxazole and furazolidone, rational 
use of fluoroquinolones, and introduction of azithromycin 
for treating diarrhea.
Conclusions
Unlike our previous study (7), in this study, factors 
involved in the virulence of NAGs were not comprehensively 
elucidated in the study region. Unlike V. cholerae O1/O139, 
the pathogenicity of NAGs has been associated with >1 
virulence factor (7,10). All NAGs lacked ctxA and El Tor 
tcpA genes. However, 6 (2.1%) strains had the tcpA gene; 
in 5 of them it was the only virulence gene detected. Most 
(94%) strains had the gene encoding El Tor type hemolysin, 
followed by rtxA (91.4%) and rtxC (75%) genes; only 5 
(1.8%) had the stn gene. The RTX family includes a group 
of protein toxins produced by gram-negative bacteria, 
including V. cholerae with hemolytic, leukotoxic, and actin 
cross-linking activities, which may play a role in virulence 
(13). In this study, prevalence of NAGs that have genes 
encoding TTSS as the only virulence factor (41 cases) was 
higher than in Bangladesh and Argentina (14,15).
Strains containing hlyA, rtxA, and rtxC genes were 
predominant, followed by strains containing hlyA-rtxA-rtxC-
TTSS and hlyA-rtxA genes (Table 3, Appendix, wwwnc.
cdc.gov/EID/article/19/3/12-1156-T3.htm). Some gene 
combinations, such as hlyA-rtxA-rtxC-TTSS, hlyA-rtxA-
rtxC, and hlyA-rtxA, were detected predominantly NAGs as 
the only virulence factor genes (online Table 3). However, 
there was no correlation between type of serogroup and 
prevalence of putative virulence gene(s). Pulsed-field 
electrophoresis profiles of 70 strains representing the 
predominant serogroups showed distinct patterns (overall 
similarity ≈70%) (Figure). There was no profile match 
among strains belonging to the same serogroup.
Prevalence of NAGs associated with severe traits of 
infection indicates the role of these pathogens in cholera. 
The pathogenic mechanism of NAGs is multifarious; 
 
 
Table	1.	Prevalence	rates	of	Vibrio cholerae non-O1,	non-O139	
strains	among	patients	with	diarrhea,	Kolkata,	India 
Year 
No.	fecal	
specimens 
No. (%)	 
Strains isolated 
Infection status 
Single Mixed 
2002 2,285 49	(2.1) 30 19 
2003 1,673 53	(3.2) 29 24 
2004 2,430 31	(1.3) 16 15 
2005 1,472 38	(2.6) 27 11 
2006 930 19	(2.0) 12 7 
2007 744 24	(3.2) 23 1 
2008 1,124 35	(3.1) 22 13 
2009 1,380 17	(1.2) 8 9 
2010 681 15	(2.2) 8 7 
Total 12,719 281	(2.2) 175 106 
 
 
 
Table	2.	Clinical	characteristics	of	Vibrio cholerae non-O1,	non-
O139	strain–infected	patients	with	diarrhea,	Kolkata,	India 
Characteristic 
Infection	status,	no.	(%) 
Single,	n	=	175 Mixed,	n	=	106 
Type	of	diarrhea   
 Watery 122	(70.0) 63	(59.4) 
    Loose	with	bloody	mucus 30	(17.1) 25	(23.6) 
    Other 23	(13.1) 18	(17.0) 
Dehydration	status   
 Severe 39	(22.3) 18	(17.0) 
    Moderate 136	(77.7) 88	(83.0) 
Age,	y   
 >5 126	(72.0) 75	(70.8) 
5 49	(28.0) 31	(29.2) 
Sex   
 M 106	(60.6) 64 (60.4) 
    F 69	(39.4) 42	(39.6) 
Fever   
 Yes 72	(41.1) 39	(36.8) 
    No 103	(58.9) 67	(63.2) 
Abdominal	pain   
 Yes 69	(39.4) 44	(41.5) 
    No 106	(60.6) 62	(58.5) 
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there are several virulence factors in genetically distinct 
strains. On the basis of our results, current antimicrobial 
drug therapy in the clinical management of NAG-mediated 
diarrhea can be continued. Further epidemiologic studies 
are needed to determine the ecology, virulence factors, and 
public health role of NAGs.
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